Section 1. Table 3.1.a Evidence Worksheet for Primary Research Report Citation:
Fawzi, W., Msamanga, G., Spiegelman, D., Wei, R.,
Kapiga, S., Villamor, E., Hunter, D. (2004). A Randomized Trial of Multivitamin Supplements and HIV Disease Progression and Mortality. New England Journal of Medicine, 351, 23-32. doi:10.1056/NEJMoa040541
Study Design: Research Purpose:
Inclusion Criteria: Exclusion Criteria: Description of Study Protocol Data Collection Summary:
Description of Actual Data Sample:
Summary of Results
The study design was a randomized trial.
The purpose of the study was to determine if supplementation of solely vitamin A, a multivitamin, or a combination of both had significant effects on the progression of human immunodeficiency virus (HIV). Women enrolled in the study lived in Tanzania, were pregnant and HIV positive. There was no exclusion criteria stated. Participants were randomly assigned to receive a daily dose of either: a multivitamin containing vitamins B, C and E, the multivitamin and vitamin A, solely vitamin A, or a placebo. Participants were followed from enrollment, between 1995 and 1997, to the end of the study in 2003. The women attended monthly physical examinations at a clinic where health and HIV status were assessed. Height, weight and the circumference of the middle arm were measured at that time. Compliance was measured by the number of tablets returned during monthly meetings. CD4+, CD8+, and CD3+ levels were measured at baseline and every 6 months after. Of the 1078 women who started the trial, 299 of these either advanced to World Health Organization (WHO) stage 4, or died from disease-related causes. At baseline, characteristics including age, education level, vitamin A, E, hemoglobin, CD4+ and CD8+ levels were similar between the four groups. Women in the multivitamin group were less likely to progress to WHO stage 4, or die from the disease compared to the group receiving the placebo (P=0.04). Multivitamin supplementation decreased HIV symptoms such as gastrointestinal and oral manifestations, rashes, fatigue, and upper respiratory tract infections. CD4+ levels were higher
Running head: ABSTRACT AND SUMMARY
Author Conclusion: Review Comments:
by 48 cells per cubic millimeter for participants taking
multivitamins than those who took placebos (P=0.01). Multivitamin supplementation is a cost-effective method to delay the development of HIV for women. Strengths of the study include time and number of participants. The study was able to follow women for extended periods of time, which allowed for greater data collection. Additionally, the number of participants allowed for more accurate results from a larger sample of the population. A limitation would be that since the trial was only conducted on pregnant women, it does not show how multivitamin supplementation can aid in slowing HIV progression in other populations.
Section 2. Use of evidence in patient care
Human immunodeficiency virus is a disease that impairs both immune system function and nutrition status. Common symptoms from HIV and its treatment are diarrhea and severe weight loss. Therefore, proper nutrition is vital in fighting the progression of HIV and associated malnutrition. According to the research presented by the New England Journal of Medicine, progression of HIV can be slowed by daily supplementation of multivitamins containing vitamins B, C and E. Similar findings were presented in the evidence analysis library with micronutrient supplementation and the progression of HIV. One study showed a 24% increase in CD4 count with micronutrient supplementation in adults with HIV. The patient I worked with was presenting severe malnutrition, with definite loss of muscle mass and subcutaneous fat. He told me that he ate 5-6 meals a day in an attempt to gain weight. Since the severe wasting is due to his diagnosis of HIV, I would suggest supplements in addition to increasing calorie intake, especially supplementation of a multivitamin containing B, C, and E. Not only would the supplement improve his nutrition status, but it would also slow the progression of his
Running head: ABSTRACT AND SUMMARY
disease, providing him a longer and healthier life. As an RD, I would present and discuss the information I found in both the research and the evidence analysis library with the patient, and encourage him to follow the recommendations set by these. Section 3. References Academy of Nutrition and Dietetics Evidence Analysis Library (2009). HIV/AIDS: Micronutrient Supplementation. Academy of Nutrition and Dietetics, https://www.andeal.org/topic.cfm?menu=5312&cat=3141 Fawzi, W., Msamanga, G., Spiegelman, D., Wei, R., Kapiga, S., Villamor, E., Hunter, D. (2004). A Randomized Trial of Multivitamin Supplements and HIV Disease Progression and Mortality. New England Journal of Medicine, 351, 23-32. doi:10.1056/NEJMoa040541